Tygh Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-55,286
| Closed | -$3.43M | – | 93 |
|
|
2020
Q4 | $3.43M | Sell |
55,286
-84,167
| -60% | -$5.22M | 0.53% | 74 |
|
|
2020
Q3 | $8.29M | Sell |
139,453
-61,084
| -30% | -$3.63M | 1.57% | 23 |
|
|
2020
Q2 | $14M | Sell |
200,537
-42,786
| -18% | -$2.99M | 2.92% | 2 |
|
|
2020
Q1 | $11M | Buy |
243,323
+154,081
| +173% | +$6.99M | 2.47% | 5 |
|
|
2019
Q4 | $5.81M | Buy |
89,242
+36,747
| +70% | +$2.39M | 0.96% | 49 |
|
|
2019
Q3 | $3.26M | Sell |
52,495
-43,425
| -45% | -$2.7M | 0.58% | 65 |
|
|
2019
Q2 | $6.83M | Buy |
95,920
+18,117
| +23% | +$1.29M | 1.16% | 39 |
|
|
2019
Q1 | $6.1M | Sell |
77,803
-50,730
| -39% | -$3.98M | 1.07% | 45 |
|
|
2018
Q4 | $10.9M | Buy |
128,533
+66,726
| +108% | +$5.65M | 2.28% | 8 |
|
|
2018
Q3 | $10.6M | Sell |
61,807
-18,011
| -23% | -$3.08M | 1.73% | 17 |
|
|
2018
Q2 | $10.3M | Sell |
79,818
-1,156
| -1% | -$149K | 1.75% | 12 |
|
|
2018
Q1 | $8.34M | Buy |
80,974
+2,688
| +3% | +$277K | 1.58% | 19 |
|
|
2017
Q4 | $6.69M | Sell |
78,286
-46,375
| -37% | -$3.96M | 1.26% | 24 |
|
|
2017
Q3 | $10.6M | Buy |
124,661
+29,836
| +31% | +$2.53M | 2.12% | 4 |
|
|
2017
Q2 | $7.18M | Buy |
+94,825
| New | +$7.18M | 1.63% | 13 |
|